Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors.
Liverani C, Spadazzi C, Ibrahim T, Pieri F, Foca F, Calabrese C, De Vita A, Miserocchi G, Cocchi C, Vanni S, Ercolani G, Cavaliere D, Ranallo N, Chiadini E, Prisinzano G, Severi S, Sansovini M, Martinelli G, Bongiovanni A, Mercatali L. Liverani C, et al. Among authors: severi s. Front Endocrinol (Lausanne). 2023 Jan 20;13:1045038. doi: 10.3389/fendo.2022.1045038. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743926 Free PMC article.
Single bone metastasis from adenocarcinoma of the lacrimal gland: a case report.
Ricci M, Amadori E, Chiesa F, Bongiovanni A, Liverani C, Fabbri L, Falasconi MC, Casadei R, Oboldi D, Galassi R, Micheletti S, Severi S, Serra L, Pieri F, Calabrese L, Riva N, Calpona S, Gunelli E, Mercatali L, Amadori D, Ibrahim T. Ricci M, et al. Among authors: severi s. Future Oncol. 2014 Aug;10(10):1735-9. doi: 10.2217/fon.14.36. Future Oncol. 2014. PMID: 25303054
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature.
Bongiovanni A, Riva N, Calpona S, Ricci M, Gunelli E, Liverani C, La Manna F, De Vita A, Monti M, Severi S, Pieri F, Amadori E, Galassi R, Cavaliere D, Zaccaroni A, Tartaglia A, Lunedei V, Gardini A, Mercatali L, Amadori D, Ibrahim T. Bongiovanni A, et al. Among authors: severi s. Onco Targets Ther. 2014 Oct 20;7:1919-26. doi: 10.2147/OTT.S68573. eCollection 2014. Onco Targets Ther. 2014. PMID: 25364262 Free PMC article.
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.
Bodei L, Kidd M, Modlin IM, Severi S, Drozdov I, Nicolini S, Kwekkeboom DJ, Krenning EP, Baum RP, Paganelli G. Bodei L, et al. Among authors: severi s. Eur J Nucl Med Mol Imaging. 2016 May;43(5):839-851. doi: 10.1007/s00259-015-3250-z. Epub 2015 Nov 23. Eur J Nucl Med Mol Imaging. 2016. PMID: 26596723
298 results